| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |